Bokus

Amir Hossein Emami – författare

Visar alla böcker från författaren Amir Hossein Emami. Handla med fri frakt och snabb leverans.

3 produkter

  1. Azin Alizadehasl, Ardeshir Ghavamzadeh, Amir Hossein Emami, Ghasem Janbabaei, Davood Khoda-Amorzideh - Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation, Inbunden. Tillgänglighet: Lägg i varukorg

    Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation

    Av Azin Alizadehasl, Ardeshir Ghavamzadeh m. fl.

    Inbunden, 2024

    1461 kr

    Lägg i varukorg

    This book discusses the epidemiology and the known cardiotoxic effects of chemoradiation agents in addition to newer therapies in hematopoietic stem cell transplantation (HSCT). Recent expert consensus statements from cardiology and hematology/oncology societies are reviewed in regard to risk …

  2. Davood Khoda-Amorzideh, Ghasem Janbabaei, Amir Hossein Emami, Ardeshir Ghavamzadeh, Azin Alizadehasl - Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation, E-bok. Tillgänglighet: Lägg i varukorg

    Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation

    Av Davood Khoda-Amorzideh, Ghasem Janbabaei m. fl.

    E-bok, 2024

    1502 kr

    Lägg i varukorg

    This book discusses the epidemiology and the known cardiotoxic effects of chemoradiation agents in addition to newer therapies in hematopoietic stem cell transplantation (HSCT). Recent expert consensus statements from cardiology and hematology/oncology societies are reviewed in regard to risk …

  3. Azin Alizadehasl, Ardeshir Ghavamzadeh, Amir Hossein Emami, Ghasem Janbabaei, Davood Khoda-Amorzideh - Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation, Häftad. Tillgänglighet: Lägg i varukorg

    Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation

    Av Azin Alizadehasl, Ardeshir Ghavamzadeh m. fl.

    Häftad, 2025

    1126 kr

    Lägg i varukorg

    This book discusses the epidemiology and the known cardiotoxic effects of chemoradiation agents in addition to newer therapies in hematopoietic stem cell transplantation (HSCT). Recent expert consensus statements from cardiology and hematology/oncology societies are reviewed in regard to risk …